| Patents for B82Y 5 - Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery (2,162) |
|---|
| 04/14/2011 | US20110086082 Composition, system, and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility |
| 04/14/2011 | US20110086073 NANOMETER-SIZED PRODRUGS OF NSAIDs |
| 04/14/2011 | US20110085972 Nanotubes for cancer therapy and diagnostics |
| 04/14/2011 | US20110085971 Nanotubes for cancer therapy and diagnostics |
| 04/14/2011 | US20110085968 Articles comprising nano-materials for geometry-guided stem cell differentiation and enhanced bone growth |
| 04/07/2011 | US20110082090 Compounds suited as nanocarriers for active agents and their use |
| 04/07/2011 | US20110082040 Composition and method for delivery of substances in a dry mode |
| 04/07/2011 | US20110081643 Flow Focusing Method and System for Forming Concentrated Volumes of Microbeads, and Microbeads Formed Further Thereto |
| 04/07/2011 | US20110081423 Tissue Stabilization for Heart Failure |
| 04/07/2011 | US20110081384 Methods of wound care and treatment |
| 03/31/2011 | US20110077201 High affinity vegf-receptor antagonists |
| 03/31/2011 | US20110076315 Grafts and Stents Having Inorganic Bio-Compatible Calcium Salt |
| 03/24/2011 | US20110071596 Electrode contacts for a medical implant |
| 03/24/2011 | US20110071280 Methods and Compositions for Concentrating Secreted Recombinant Proteins |
| 03/24/2011 | US20110070604 Analysis of ex vivo cells for disease state detection and therapeutic agent selection and monitoring |
| 03/24/2011 | US20110070440 Artificial Organelle On A Digital Microfluidic Chip Used To Redesign The Biological Activities of Heparan Sulfate |
| 03/24/2011 | US20110070293 Methods for the Preparation of Liposomes Comprising Docetaxel |
| 03/24/2011 | US20110070292 Methods For The Preparation Of Liposomes |
| 03/24/2011 | US20110070154 Artificial cells |
| 03/24/2011 | US20110068497 Preparation of nanoparticles by using a vibrating nozzle device |
| 03/17/2011 | US20110065829 Biodegradable copolymer and thermosensitive material |
| 03/17/2011 | US20110064825 Method for preparing dispersions of precious metal nanoparticles and for isolating such nanoparticles from said dispersions |
| 03/17/2011 | US20110064821 Encapsulation of biologically active agents |
| 03/17/2011 | US20110064819 Encapsulation of biologically active agents |
| 03/17/2011 | US20110064818 Pharmaceutical composition and a method for the production thereof |
| 03/17/2011 | US20110064815 Silicia for the inhinition of a protease |
| 03/17/2011 | US20110064800 Nanoparticulate and controlled release compositions comprising cyclosporine |
| 03/17/2011 | US20110064794 Drug Delivery System, its Preparation Process and Use |
| 03/17/2011 | US20110064785 Nanostructure-Enhanced Platelet Binding and Hemostatic Structures |
| 03/17/2011 | US20110064776 Dental composition containing organic nanotube |
| 03/17/2011 | US20110064775 Metallo-organic system for the encapsulation and release of compounds of interest, method for obtaining same and uses thereof |
| 03/17/2011 | US20110064652 Nanoparticles for targeted delivery of active agents to the lung |
| 03/10/2011 | US20110060073 Methods For Fabricating Polymer-Bioceramic Composite Implantable Medical Devices |
| 03/10/2011 | US20110060036 Branched Multifunctional Nanoparticle Conjugates And Their Use |
| 03/10/2011 | US20110059181 Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles |
| 03/10/2011 | US20110059180 Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059142 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059017 Polymer coated sers nanotag |
| 03/03/2011 | US20110054392 Implant Material Based On A Polymer System And The Use Thereof |
| 03/03/2011 | US20110054236 Compositions and methods for targeting tumors |
| 03/03/2011 | US20110053284 Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| 03/03/2011 | US20110052917 Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof |
| 03/03/2011 | US20110052715 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 03/03/2011 | US20110052709 Novel nanoparticles for delivery of active agents |
| 03/03/2011 | US20110052703 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| 03/03/2011 | US20110052702 Method and Apparatus for Producing Organic Nanotubes |
| 03/03/2011 | US20110052698 Novel material with bacteriostatic properties |
| 03/03/2011 | US20110052672 Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy |
| 03/03/2011 | US20110052671 Near infra-red pulsed laser triggered drug release from hollow nanoshell disrupted vesicles and vesosomes |
| 03/03/2011 | US20110052668 Identification and Characterization of a Specific CCK-C Receptor Antibody for Human Pancreatic Cancer and Its Use for Early Detection and Staging of Pancreatic Cancer |
| 03/03/2011 | US20110052508 Peptide-based oral care surface reagents for personal care |
| 03/03/2011 | US20110052495 Use of fullerenes in photoacoustic imaging |
| 02/24/2011 | US20110046711 Strengthening textures in medical devices |
| 02/24/2011 | US20110046345 Methods for preparing linked peptide rings and peptide nanotubes obtained thereby |
| 02/24/2011 | US20110045094 Encapsulated quantum dot |
| 02/24/2011 | US20110045092 Casein particles encapsulating therapeutically active agents and uses thereof |
| 02/24/2011 | US20110045081 Magnetic, paramagnetic and/or superparamagnetic nanoparticles |
| 02/24/2011 | US20110045080 Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto |
| 02/24/2011 | US20110045041 Compositions and methods for the delivery of agents |
| 02/24/2011 | US20110045031 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 02/24/2011 | US20110044911 Use of Functionalized Magnetic Nanoparticles in Cancer Detection and Treatment |
| 02/23/2011 | EP2285913A2 Platelet-shaped, copper-containing, metallic effect pigments, process for preparing them and use thereof |
| 02/17/2011 | US20110039947 Surface-modified nanoparticles |
| 02/17/2011 | US20110038942 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
| 02/17/2011 | US20110038939 Therapeutic stable nanoparticles |
| 02/17/2011 | US20110038909 System and Method for Using Nanoparticles for Antimicrobial Activity |
| 02/17/2011 | US20110038905 Skin anti-aging agent for external use |
| 02/17/2011 | US20110038900 Nanoparticles for use in pharmaceutical compositions |
| 02/10/2011 | US20110034916 Nanoparticle-mediated microwave treatment methods |
| 02/10/2011 | US20110033954 Biofunctionalized quantum dots for biological imaging |
| 02/10/2011 | US20110033661 Controllable nanostructuring on micro-structured surfaces |
| 02/10/2011 | US20110033547 Dehydrated chitosan nanoparticles |
| 02/10/2011 | US20110033525 Diterpene Glycosides as Natural Solubilizers |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110030885 Prosthetic device including electrostatically spun fibrous layer and method for making the same |
| 02/09/2011 | EP2281576A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 02/03/2011 | US20110027851 Compositions, methods and uses for biosynthetic plasmid integrated capture elements |
| 02/03/2011 | US20110027379 Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
| 02/03/2011 | US20110027174 Nanotubes for cancer therapy and diagnostics |
| 01/27/2011 | US20110021970 Non-invasive energy upconversion methods and systems for in-situ photobiomodulation |
| 01/19/2011 | EP2275094A2 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| 01/05/2011 | EP2269065A2 Methods and reagents to increase the sensitivity of enzyme metallographic detection |
| 12/29/2010 | EP2266544A2 Method for encapsulating therapeutic substances in cells |
| 12/15/2010 | EP2260871A2 Inclusion complexes comprising piroxicam, a cyclodextrin and arginine |
| 11/24/2010 | EP2252261A2 Drug delivery system with stabilising effect |
| 11/17/2010 | EP2250190A1 Optimized adhesin fragments and corresponding nanoparticles |
| 10/20/2010 | EP2241314A1 Alpha-lipoic acid nanoparticle and method for producing the same |
| 10/06/2010 | EP2234614A2 Pharmaceutical composition |
| 09/08/2010 | EP2224914A2 Rhein or diacerein compositions |
| 08/18/2010 | EP2217063A1 Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents |
| 08/11/2010 | EP2215107A1 Peptide ligand directed drug delivery |
| 08/11/2010 | EP2214719A2 Metallofullerene contrast agents |
| 07/14/2010 | EP2205291A1 Drug-eluting nanowire array |
| 07/14/2010 | EP2205284A2 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 05/19/2010 | EP2185161A2 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of nf-kb |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/21/2010 | EP2175841A1 Osteopontin nanoparticles system for drug delivery |
| 04/14/2010 | EP2173430A1 Systems and methods for particle radiation enhanced delivery of therapy |
| 04/14/2010 | EP2173357A2 Metal complexes incorporated within biodegradable nanoparticles and their use |